These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 22032272
1. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. Coulthart MB, Jansen GH, Olsen E, Godal DL, Connolly T, Choi BC, Wang Z, Cashman NR. BMC Neurol; 2011 Oct 27; 11():133. PubMed ID: 22032272 [Abstract] [Full Text] [Related]
2. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ. J Neurol Neurosurg Psychiatry; 2010 Nov 27; 81(11):1243-8. PubMed ID: 20855493 [Abstract] [Full Text] [Related]
6. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result. Leitão MJ, Baldeiras I, Almeida MR, Ribeiro MH, Santos AC, Ribeiro M, Tomás J, Rocha S, Santana I, Oliveira CR. J Neurol; 2016 Sep 27; 263(9):1847-61. PubMed ID: 27357003 [Abstract] [Full Text] [Related]
7. Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders. Singh A, Beveridge AJ, Singh N. PLoS One; 2011 Mar 09; 6(3):e16804. PubMed ID: 21408069 [Abstract] [Full Text] [Related]
8. Cerebrospinal fluid non-phosphorylated tau in the differential diagnosis of Creutzfeldt-Jakob disease: a comparative prospective study with 14-3-3. Llorens F, Villar-Piqué A, Hermann P, Schmitz M, Goebel S, Waniek K, Lachmann I, Zerr I. J Neurol; 2020 Feb 09; 267(2):543-550. PubMed ID: 31701333 [Abstract] [Full Text] [Related]